אוברלוי 100 מג ישראל - עברית - Ministry of Health

אוברלוי 100 מג

abbvie biopharmaceuticals ltd, israel - ubrogepant as trihydrate - טבליה - ubrogepant as trihydrate 100 mg

אוברלוי 50 מג ישראל - עברית - Ministry of Health

אוברלוי 50 מג

abbvie biopharmaceuticals ltd, israel - ubrogepant as trihydrate - טבליה - ubrogepant as trihydrate 50 mg

קיוליפטה 10 מג ישראל - עברית - Ministry of Health

קיוליפטה 10 מג

abbvie biopharmaceuticals ltd, israel - atogepant as monohydrate - טבליה - atogepant as monohydrate 10 mg - atogepant

קיוליפטה 30 מג ישראל - עברית - Ministry of Health

קיוליפטה 30 מג

abbvie biopharmaceuticals ltd, israel - atogepant as monohydrate - טבליה - atogepant as monohydrate 30 mg - atogepant

קיוליפטה 60 מג ישראל - עברית - Ministry of Health

קיוליפטה 60 מג

abbvie biopharmaceuticals ltd, israel - atogepant as monohydrate - טבליה - atogepant as monohydrate 60 mg - atogepant

תרומביקסיל ישראל - עברית - Ministry of Health

תרומביקסיל

omrix biopharmaceuticals - calcium chloride 5.6 - 6.2 mg; human thrombin 800 - 1200 iu - solution - thrombin - as an aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standart surgical techniques is ineffective or impractical.

זמפלר 1 מיקרוגרם ישראל - עברית - Ministry of Health

זמפלר 1 מיקרוגרם

abbvie biopharmaceuticals ltd, israel - paricalcitol - קפסולות - paricalcitol 1 mcg - paricalcitol - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

אומר-יג-אם % 5 ישראל - עברית - Ministry of Health

אומר-יג-אם % 5

omrix biopharmaceuticals - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 50 mg/ml mg/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy * primary immunodeficiency (patients with primary defective antibody synthesis such as agammaglobulinemia or hypogammaglobulinemia) * myeloma or chronic lymphocytic leukemia (cll) with severe secondary hypogammaglobulinemia and recurrent infections. * children with congenital aids and recurrent infections - immunomodulation * idiopathic thrombocytopenic purpura (itp) * guillain barre syndrome * kawasaki disease - allogenic bone marrow transplantation

לוקרין פ.ד.ס  דפו 11.25 מג ישראל - עברית - Ministry of Health

לוקרין פ.ד.ס דפו 11.25 מג

abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 11.25 mg - leuprorelin

לוקרין פ.ד.ס  דפו 11.25 מג ישראל - עברית - Ministry of Health

לוקרין פ.ד.ס דפו 11.25 מג

abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 11.25 mg - leuprorelin